Skip to Main Content

Author Details

Fang Liu
Chengdu Military General Hospital
2006
11
9
PMIDPaper TitleJournal TitlePublished Year
35091541Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia.Blood Cancer J2022
35402194Overexpression of F-box and WD repeat domain containing 7 prevents tumor growth of bladder cancer cells through regulating SREBP1a.Transl Androl Urol2022
35091541Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia.Blood Cancer J2022
35402194Overexpression of F-box and WD repeat domain containing 7 prevents tumor growth of bladder cancer cells through regulating SREBP1a.Transl Androl Urol2022
33560141Circ_0000735 enhances the proliferation, metastasis and glycolysis of non-small cell lung cancer by regulating the miR-635/FAM83F axis.Exp Lung Res2021
33560141Circ_0000735 enhances the proliferation, metastasis and glycolysis of non-small cell lung cancer by regulating the miR-635/FAM83F axis.Exp Lung Res2021
33061574Knockdown of PVT1 Suppresses Colorectal Cancer Progression by Regulating MiR-106b-5p/FJX1 Axis.Cancer Manag Res2020
33061574Knockdown of PVT1 Suppresses Colorectal Cancer Progression by Regulating MiR-106b-5p/FJX1 Axis.Cancer Manag Res2020
22028491Polycomb repressor complex-2 is a novel target for mesothelioma therapy.Clin Cancer Res2012
22555974Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer.Blood2012
22028491Polycomb repressor complex-2 is a novel target for mesothelioma therapy.Clin Cancer Res2012
22555974Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer.Blood2012
21546573Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer.Cancer Res2011
21829468The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes.PLoS One2011
21546573Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer.Cancer Res2011
21829468The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes.PLoS One2011
20440268Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate.Oncogene2010
20440268Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate.Oncogene2010
19351856Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells.Cancer Res2009
19351856Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells.Cancer Res2009
16884923Purification, crystallization and preliminary X-ray diffraction analysis of the phage T4 vertex protein gp24 and its mutant forms.Protein Expr Purif2006
16884923Purification, crystallization and preliminary X-ray diffraction analysis of the phage T4 vertex protein gp24 and its mutant forms.Protein Expr Purif2006
  • 1 - 22 of 22

Recommended Authors

Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 0
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 1
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
West China Hospital, Sichuan University
Career Start Year 2010
Number of shared co-authors 0
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Montefiore Medical Center
Career Start Year 2008
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 6
College of Biology and Food, Shangqiu Normal University
Career Start Year 2007
Number of shared co-authors 0
The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)
Career Start Year 2006
Number of shared co-authors 0
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 0
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
College of Life Science, CHA University
Career Start Year 2003
Number of shared co-authors 0
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 4
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 0
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 1
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 0

Collaborators

Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
College of Basic Medicine, Army Medical University
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
University of Colorado School of Medicine
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
University of Chicago Medical Center
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Thoracic and GI Oncology Branch National Cancer Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
From Foundation Medicine
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Co-authored papers 1
Center for Cancer Research
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1